Literature DB >> 8671629

Functional significance of the Fas molecule in naive lymphocytes.

S Senju1, I Negishi, N Motoyama, F Wang, K Nakayama, K Nakayama, P J Lucas, S Hatakeyama, Q Zhang, S Yonehara, D Y Loh.   

Abstract

The Fas molecule mediates apoptotic signal in many cell types. Mouse mutations (lpr, lprcg, gld), which impair the function of Fas, cause spontaneous autoimmune disease. We generated Fas-deficient (Fas-/-) mice by homologous recombination. In embryonic stem cells Fas-/- mice developed lpr-like disease, confirming that the abnormality of Fas is causal in the lpr phenotype. We also made Fas-/- chimeric mice composed of a mixture of Fas+/+ and Fas-/- cells. The chimeric mice also showed the lpr phenotype. In Fas-/-, chimeric mice, the Fas-deficient population expanded progressively among mature T and B lymphocytes. The expansion of Fas-deficient lymphocytes occurred at the naive, pre-primed, lymphocyte stage. These results suggest that the Fas molecule functions not only after antigenic stimulation, as previously hypothesized, but also at the naive lymphocyte stage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8671629     DOI: 10.1093/intimm/8.3.423

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

1.  FasL expression in activated T lymphocytes involves HuR-mediated stabilization.

Authors:  Gillian L Drury; Sergio Di Marco; Virginie Dormoy-Raclet; Julie Desbarats; Imed-Eddine Gallouzi
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

2.  Utility of antiPax5 in the diagnosis of lymphoproliferative disorders and neoplasia in mice.

Authors:  Jerold E Rehg; John P Sundberg
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

3.  DICE: A novel tumor surveillance mechanism-a new therapy for cancer?

Authors:  Marcus E Peter
Journal:  Cell Cycle       Date:  2014-04-01       Impact factor: 4.534

4.  Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor.

Authors:  P J Lucas; S J Kim; S J Melby; R E Gress
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

5.  A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice.

Authors:  S L Peng; M E Robert; A C Hayday; J Craft
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

Review 6.  The role of CD95 and CD95 ligand in cancer.

Authors:  M E Peter; A Hadji; A E Murmann; S Brockway; W Putzbach; A Pattanayak; P Ceppi
Journal:  Cell Death Differ       Date:  2015-02-06       Impact factor: 15.828

Review 7.  Stress Management: Death Receptor Signalling and Cross-Talks with the Unfolded Protein Response in Cancer.

Authors:  Elodie Lafont
Journal:  Cancers (Basel)       Date:  2020-04-29       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.